tradingkey.logo

BRIEF-Aurobindo Pharma Says US FDA Inspection At Aurobindo Pharma USA Warehouse Concludes With 5 Observations

ReutersFeb 20, 2025 2:21 AM

- Aurobindo Pharma Ltd ARBN.NS:

  • AUROBINDO PHARMA - US FDA INSPECTION AT AUROBINDO PHARMA USA WAREHOUSE CONCLUDES WITH 5 OBSERVATIONS

  • AUROBINDO PHARMA - US FDA INSPECTION CLASSIFICATION STATUS OF FACILITY AS OFFICIAL ACTION INDICATED

Source text: ID:nBSE4GWt5T

Further company coverage: ARBN.NS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI